Concepedia

Author

Jana L. Laidlaw

Anderson Hospital

Also Known As

J L Laidlaw, J. L. LAIDLAW, Jana L. Laidlaw, Jana Laidlaw

9

Publications

610

Citations

7

H-Index

42

Concepts

All Affiliations

Anderson HospitalThe University of Texas Health Science Center at HoustonThe University of Texas System
JL

About

Jana L. Laidlaw is an author at Anderson Hospital specializing in medicine, pharmacology, and biomedical engineering.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

606

2

Biomedical Engineering

3

3

222

3

Allergy

2

2

45

4

Engineering

1

1

52

5

Health Sciences

1

1

12

Jana L. Laidlaw

×

7

Publications

606

Citations

7

H-Index

YearCitations

PA26, a novel target of the p53 tumor suppressor and member of the GADD family of DNA damage and growth arrest inducible genes

Susana Velasco-Miguel, Leonard Buckbinder, Patrice Jean,

Oncogene

1999

253

The effect of proteoglycans on the formation of fibrils from collagen solutions

Theodore R. Oegema, Jana L. Laidlaw, Vincent Hascall,

Archives of Biochemistry and Biophysics

1975

137

Degradation and Inactivation of Antitumor Drugs

John A. Benvenuto, Thomas H. Connor, David Monteith,

Journal of Pharmaceutical Sciences

1993

94

Permeability of latex and polyvinyl chloride gloves to 20 antineoplastic drugs

Jana L. Laidlaw, Thomas H. Connor, Jeffrey C. Theiss,

American Journal of Health-System Pharmacy

1984

52

Permeability of latex and polyvinyl chloride gloves to carmustine

Thomas H. Connor, Jana L. Laidlaw, Jeffrey C. Theiss,

American Journal of Health-System Pharmacy

1984

33

Inhibition of T-lymphocyte proliferation by the cyclic polypeptide didemnin B: no inhibition of lymphokine stimulation.

Stephen J. LeGrue, Tsai-Ling Sheu, Daniel D. Carson,

PubMed

1988

25

Permeability of four disposable protective-clothing materials to seven antineoplastic drugs.

Jana L. Laidlaw, Thomas H. Connor, Jeffrey C. Theiss,

PubMed

1985

12

Page 1